Diagnostic concordance between BioFire® FilmArray® Pneumonia Panel and culture in patients with COVID-19 pneumonia admitted to intensive care units: the experience of the third wave in eight hospitals in Colombia

Table 4 Results of laboratory tests of inflammatory response among patients with or without pulmonary coinfection

Combination of tests	Laboratory	Me	P25	P75	Min	Max	n
FA-PNEU (+) culture (+)	Procalcitonin (ng/mL)	0.13	0.09	0.53	0.05	1.66	13
	C-reactive protein (mg/dL)	16.02	8.6	21.86	1.33	36.8	17
	Leukocytes (cell numbers × 10⁶/mL)	11.05	6.92	13.5	4.45	28.3	18
FA-PNEU (−) culture (−)	Procalcitonin (ng/mL)	0.23	0.10	0.6	0.05	27.4	69
	C-reactive protein (mg/dL)	17.0	10.68	24.87	2.25	46.9	80
	Leukocytes (cell numbers × 10⁶/mL)	10.1	7.46	13.5	3.58	16.04	80
^aFA-PNEU (+) culture (−)	Procalcitonin (ng/mL)	0.56	0.13	0.97	0.06	1.02	4
	C-reactive protein (mg/dL)	19.84	14.20	19.99	0.15	21.1	5
	Leukocytes (cell numbers × 10⁶/mL)	14.85	13.6	20.39	9.94	28.8	5
^bFA-PNEU (+) culture (−)	Procalcitonin (ng/mL)	0.07	0.05	0.27	0.05	0.27	3
	C-reactive protein (mg/dL)	9.85	9.02	24.18	5.58	25.07	6
	Leukocytes (cell numbers × 10⁶/mL)	10.22	9.8	11.5	9.5	18.87	6

Me, Median; P25–P75, 25th and 75th percentiles; Min, minimum; Max, maximum; n, number of observations; FA-PNEU, BioFire® FilmArray® Pneumonia Panel
^aBioFire® FilmArray® Pneumonia Panel with a count of ≥ 10⁵ copies/mL
^bBioFire® FilmArray® Pneumonia Panel with a count of < 10⁵ copies/mL

ISSN: 1364-8535